Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Interleukin 1 Receptor Accessory Protein (IL1RAP) is an essential co-receptor for several interleukin receptors, including IL1R1, IL-33 receptor, and IL-36 receptor. It mediates immune responses via cytokine-induced inflammation and participates in both innate and adaptive immunity. Aberrant activation of IL1RAP pathways contributes to autoimmune disorders, chronic inflammatory conditions, neurodegenerative diseases, fibrotic diseases, and cancer. It is being explored as a therapeutic target for eliminating malignant cells.
Monoclonal antibodies against IL1RAP block IL-1, IL-33, and IL-36 signaling.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Interleukin 1 Receptor Accessory Protein (IL1RAP).